Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00240981 · ClinicalTrials.gov registry record · Phase 4
TOM: Testosterone in Older Men With Sarcopenia
A Phase 4 study, sponsored by Boston Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 209
- Enrollment target
NCT00240981 is a Phase 4 study that was terminated before completion, run by Boston Medical Center. The registered enrollment target is 209 participants.
The verdict
NCT00240981, a Phase 4 study, was terminated before completion, sponsored by Boston Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 209 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether testosterone replacement in older men with low testosterone levels will increase muscle strength, improve physical performance and overall sense of well being, and reduce fatigue.
Interventions
- DRUG Topical testosterone gel 1% (active formulation)
- DRUG Topical gel (placebo formulation)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00240981
The ClinicalTrials.gov registry entry for NCT00240981 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topical testosterone gel 1% (active formulation) is the first listed.
NCT00240981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00240981 about?
NCT00240981 is a clinical study titled "TOM: Testosterone in Older Men With Sarcopenia". The purpose of this study is to determine whether testosterone replacement in older men with low testosterone levels will increase muscle strength, improve physical performance and overall sense of well being, and reduce fatigue.
What is the current status of trial NCT00240981?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 209 participants. The study started on 2005-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00240981?
The interventions under investigation include: Topical testosterone gel 1% (active formulation) (DRUG), Topical gel (placebo formulation) (DRUG).
Who is sponsoring clinical trial NCT00240981?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.